Insmed
INSM
INSM
116 hedge funds and large institutions have $1.33B invested in Insmed in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 56 increasing their positions, 25 reducing their positions, and 22 closing their positions.
Holders
116
Holders Change
-3
Holders Change %
-2.52%
% of All Funds
3.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
56
Reduced
25
Closed
22
Calls
$5.02M
Puts
$6.77M
Net Calls
-$1.75M
Net Calls Change
-$1.28M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$41.7M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$225M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$47.4M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$50.8M |
| 5 |
5
Morgan Stanley
New York
|
$18.9M |
Top Sellers
| 1 |
DM
1
Deerfield Management
New York
|
$21.8M |
| 2 |
TCP
2
Tourbillon Capital Partners
New York
|
$17.1M |
| 3 |
RG
3
Redmile Group
San Francisco,
California
|
$21.2M |
| 4 |
4
Citigroup
New York
|
$444K |
| 5 |
5
Stifel Financial
St. Louis,
Missouri
|
$3.22M |
